Test Price
2,800 AED✅ Home Collection Available
LAMC1 Gene Pelvic Organ Prolapse, LAMC1‑Related Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post-test clinical guidance for result interpretation with our DHA-licensed genetic counsellors.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The LAMC1 Gene Pelvic Organ Prolapse, LAMC1‑Related Genetic Test analyses the entire coding region of the LAMC1 gene using Next‑Generation Sequencing to detect pathogenic variants linked to pelvic organ prolapse and dysmorphology syndromes. This NGS-based assay provides comprehensive coverage for single nucleotide variants, small insertions and deletions, and copy number variations across the gene.
| Feature | Our NGS Test (LAMC1 Full Gene) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – complete gene coverage | Sanger Sequencing – limited to known hotspots |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Variant Detection | 99.9% sensitivity for SNVs, indels, CNVs | ~95% for targeted regions only |
| Sample Acceptability | Blood, Extracted DNA, or One Drop Blood on FTA Card | Whole Blood only |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I emphasize that this LAMC1 genetic test provides definitive molecular insights into pelvic organ prolapse predisposition. However, genetic results must always be contextualized within the patient's full clinical presentation and family history. I strongly recommend post-test counseling to integrate these findings into a personalized management plan."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory
Genetic test results should never replace ongoing medical treatment or surveillance. Continue all prescribed therapies and scheduled follow-up appointments unless explicitly advised otherwise by your managing specialist. A genetic finding does not warrant independent changes to your medication or intervention plan.
Exclusion Criteria & Safety Red Flags
- Inability to provide informed consent (guardian required for minors per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Unstable clinical condition that would make sample collection unsafe (assessed by our mobile phlebotomist).
- Severe bleeding disorder or active infection at planned draw site.
- Seek emergency care immediately if you experience: sudden severe pelvic pain, complete urinary retention, or profuse vaginal bleeding.
Patient FAQ & Clinical Guidance
1. What does the LAMC1 genetic test detect and who should consider it?
This NGS test detects pathogenic mutations in the LAMC1 gene that cause pelvic organ prolapse and associated dysmorphology. It is indicated for individuals with early‑onset prolapse, a family history of connective tissue disorders, or clinical signs requiring molecular confirmation for targeted management.
2. How is the home blood collection process arranged and is it safe?
Our DHA‑licensed phlebotomists arrive with full cold‑chain equipment. A single drop of blood on an FTA card or a standard venous draw is performed under strict aseptic technique, with samples transported at 2‑8°C directly to our ISO‑certified laboratory, ensuring complete specimen integrity.
3. What does a positive LAMC1 result mean for treatment planning?
A positive result confirms a genetic predisposition to pelvic organ prolapse and may guide surveillance frequency, surgical planning, and family counselling. Your specialist will integrate this molecular data with your clinical history to develop a personalised care pathway.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
All genetic testing services at DNA Labs UAE operate in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient genomic data is encrypted, access-controlled, and processed solely for diagnostic purposes with explicit consent. Clinical safety and patient consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Your data remains confidential and is never shared with third parties without your written authorisation. DNA Labs UAE is DHA-licensed and ISO-accredited, ensuring the highest standards of laboratory practice and information governance.
Clinical & Logistical Metadata
| Test Name | LAMC1 Gene Pelvic Organ Prolapse, LAMC1‑Related Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Blood (Whole Blood or FTA Card) or Extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | N81.9, Q87.89, Z13.79 |
| LOINC Code | 86299-5 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians